Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice

Anatomical Record

Volumn 266, Issue 4, 2002, Pages 218-225

  Oshiro, Takahiro ^a   Shiotani, Aya ^a   Shibasaki, Yoshinobu ^a   Sasaki, Takahisa ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Osteoclast; Osteoprotegerin; Osteoprotegerin deficient mice; Periodontal tissue; Receptor activator of NFKB ligand; Tooth movement

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR RECEPTOR;

ALVEOLAR BONE; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE REMODELING; FIBROBLAST; FORCE; IMMUNOCYTOCHEMISTRY; INCISOR; MAXILLA; MOUSE; MULTINUCLEAR CELL; NONHUMAN; ORTHODONTICS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ACID PHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANIMALS; BONE REMODELING; CARRIER PROTEINS; GLYCOPROTEINS; IMMUNOENZYME TECHNIQUES; INCISOR; ISOENZYMES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPROTEGERIN; PERIODONTIUM; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TOOTH MOVEMENT;

EID: 0036533589     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.10061     Document Type: Article

References (31)

1. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclasts
2. Osteoprotegerin mitigates tail suspension-induced osteopenia
3. Osteoprotegerin-deficient mice develop early onset osteopororsis and arterial calcification
4. H-ATPase inhibitor, bafilomycin Al, reduces bone resorption during experimental movement of rat molars
5. TRANCE is necessary and sufficient for osteoclast-mediated activation of bone resorption in osteoclasts
6. Osteoclast differentiation factor act as a multifunctional regulator in murine osteoclast differentiation and function
7. Localization of RANKL (receptor activator of NFKB ligand) mRNA and protein in skeletal and extraskeletal tissues
8. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
9. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
10. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
11. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
12. Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
13. Messenger RNA level and protein localization of transforming growth factor-β1 in experimental tooth movement in rats
14. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane
15. Osteopetrosis
16. The osteoclast in Paget's disease of bone
17. Effects of bisphosphonate administration on root and bone resorption during experimental movement of rat molars
18. +-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars
19. Localization of receptor activator of NFKB ligand, RANKL, in periodontal tissues during experimental movement of rat molars
20. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
21. Modulation of osteoclast differentiation
22. Transforming growth factor-βstimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
23. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production
24. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
25. 3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone
26. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation facor/RANKL but not macrophage colony-stimulating factor
27. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
28. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis
29. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
30. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/ RANKL
31. +-ATPase